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Abstract: Endocytosis is a fundamental process involved in trafficking of various extracellular
and transmembrane molecules from the cell surface to its interior. This enables cells to
communicate and respond to external environments, maintain cellular homeostasis, and transduce
signals. G protein-coupled receptors (GPCRs) constitute a family of receptors with seven
transmembrane alpha-helical domains (7TM receptors) expressed at the cell surface, where they
regulate physiological and pathological cellular processes. Several herpesviruses encode receptors
(vGPCRs) which benefits the virus by avoiding host immune surveillance, supporting viral
dissemination, and thereby establishing widespread and lifelong infection, processes where receptor
signaling and/or endocytosis seem central. vGPCRs are rising as potential drug targets as exemplified
by the cytomegalovirus-encoded receptor US28, where its constitutive internalization has been
exploited for selective drug delivery in virus infected cells. Therefore, studying GPCR trafficking is
of great importance. This review provides an overview of the current knowledge of endocytic and
cell localization properties of vGPCRs and methodological approaches used for studying receptor
internalization. Using such novel approaches, we show constitutive internalization of the BILF1
receptor from human and porcine γ-1 herpesviruses and present motifs from the eukaryotic linear
motif (ELM) resources with importance for vGPCR endocytosis.
Keywords: endocytosis; G-protein coupled receptors; herpesvirus; methods
1. Importance of Endocytosis for Viral GPCRs
Endocytosis encompasses different routes by which a cell uptakes extracellular material from the
surface and transports it into the cell thereby maintaining homeostasis between the extracellular and
intracellular environment [1]. Nutrients, receptor-ligand complexes, extracellular matrix, cell debris,
bacteria, and viruses can enter the cell by different endocytic mechanisms [2,3]. Importantly, endocytosis
is also linked with cellular signaling at the plasma membrane (PM) where receptors bind specific
signaling molecules and initiate internalization [4].
Receptors located at the cell surface coordinate many different physiological processes in the cell.
Among them, G protein coupled receptors (GPCRs) with seven transmembrane domains (7TM) are a
major family of receptors able to stimulate important intracellular signaling pathways in response to
various extracellular stimuli [5]. It has been recognized that after initial activation and desensitization
Molecules 2020, 25, 5710; doi:10.3390/molecules25235710 www.mdpi.com/journal/molecules
Molecules 2020, 25, 5710 2 of 23
on the cell membrane, GPCRs subsequently enter the cell via endocytosis. Endocytosis can occur either
constitutively (without ligand stimulus) or in response to certain stimuli, including growth factors,
viruses (Ebola, SARS and other coronaviruses), and different ligands [6]. In the cell, further sorting of
internalized GPCRs between degradation and recycling pathways occurs. Therefore, cells can tightly
regulate GPCR surface availability for further signaling events [7].
Endocytosis is also a mechanism used by several herpesviruses (for example Epstein-Barr virus,
Kaposi’s sarcoma associated herpesvirus, cytomegalovirus, and varicella zoster virus) for initial entry
into the cell [8]. Herpesviruses are widespread DNA viruses employing a special bipartite life cycle
where latent and lytic phases interchange in order to persist in the infected host for their whole life [9].
The herpesvirus virion consists of three main parts: a nucleocapsid containing linear double-stranded
DNA, an envelope, and tegument. In the envelope, different glycoproteins are involved in the initial
binding and endocytosis events upon infection of susceptible cells. Herpesvirus genomes encode
between 100 to 200 proteins. These proteins are involved in DNA replication (e.g., DNA polymerase),
viral entry, cell-to-cell spread, immunevasion, and pathogenesis. Among these regulatory proteins,
herpesviruses encode GPCRs (vGPCRs). It is believed that during evolutionary processes, viruses took
over genes for these receptors from their hosts and rearranged them to function in the benefit of the
virus [10–12]. They imitate the function of endogenous human receptors and therefore use them to
subvert cellular signaling, avoid cell immune responses, induce cell transformation, and support viral
dissemination and replication [12,13].
Many vGPCRs resemble endogenous chemokine receptors structurally, and bind a broad spectrum
of both endogenous and virally encoded chemokines, leading to activation of downstream signaling
pathways [12,14]. Others are described as “orphan” vGPCRs for which no ligand has yet been identified.
Additionally, BILF1 receptors, encoded by gamma-1 herpesviruses, have recently been recognized
as the first immune evasive vGPCR able to downregulate surface MHC class I molecules at the cell
surface [15]. Initial localization of these receptors in the cell, and additional trafficking, are important
processes that control the signaling capacity of these receptors. Table 1 summarizes known viruses and
viral GPCRs from the β- and γ-herpesvirus family and their known endocytic and signaling pathways.
In this article, the most common endocytic pathways employed by GPCRs to enter the cell are
reviewed, alongside the novel approaches used to study GPCR mediated endocytosis and endocytic
properties of most commonly studied vGPCRs: US28, ORF74, and BILF1.
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Table 1. Examples of viral GPCRs (vGPCRs) from different herpesvirus families (β and γ) (Adapted from [16]).
Family Virus Receptor Preferred EndocyticPathway Signaling Pathways G Protein Coupling






NFκB, NFAT, CREB, PLC, SRF,
STAT3, TCF/LEF, Ligand induced
PLC, MAPK
Gαq, Gαi/o, Gα12/13
UL33 - ConstitutiveSRC, CREB Gαq, Gαi, Gαs
UL78 - - -
Human herpesvirus 6 U12 - - -
U51 - - -
Human herpesvirus 7 U12 - - -
U51 - - -
Mouse cytomegalovirus M33 - ConstitutivePLC, NFκB, CREB Gαs
M78 - - -
Rat cytomegalovirus R33 - ConstitutivePLC, NFκB Gαq, Gαi
R78 - - -
γ-Herpesviruses
Human herpesvirus 8 (HHV8 or







Constitutive and ligand induced





Ateles herpesvirus (AtHV) ORF74-AtHV - - -
MouseHV68 ORF74-MHV68 - not constitutively activePLC, MAPK, Akt, NFκB Gαi
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Table 1. Cont.
Family Virus Receptor Preferred EndocyticPathway Signaling Pathways G Protein Coupling
γ-Herpesviruses Equine HV2 (EHV2) E1 - - -
E6 - - -
ORF74-EHV2 - - Gαi
Herpesvirus Saimiri (HVS) ECRF3 - - -










1 (PtroLCV1) BILF1 -
Constitutive
NFκB Gαi
Gorilla gorilla lymphocryptovirus 1
(GgorLCV1) BILF1 - - -
Gorilla gorilla lymphocryptovirus 2
(GgorLCV2) BILF1 - - -
Pongo pygmaeus




lymphocryptovirus 2 (PpygLCV2) BILF1 - - -
Symphalangus syndactylus




lymphocryptovirus 2 (SsynLCV2) BILF1 - - -
Molecules 2020, 25, 5710 5 of 23
Table 1. Cont.
Family Virus Receptor Preferred EndocyticPathway Signaling Pathways G Protein Coupling
γ-Herpesviruses Macaca fascicularislymphocryptovirus 1 (MfasLCV1) BILF1 - - -
Erythrocebus patas
lymphocryptovirus 1 (EpatLCV1) BILF1 - - -
Piliocolobus badius
lymphocryptovirus 1 (PbadLCV1) BILF1 - - -
Ateles paniscus lymphocryptovirus
1 (ApanLCV1) BILF1 - - -
Pithecia pithecia
lymphocryptovirus 1 (Ppit LCV1) BILF1 - - -
Porcine lymphotropic herpesvirus
1, 2 and 3 (PLHV1-3) BILF1 - - -
protein kinase B (Akt), cAMP responsive element binding protein (CREB), glycogen synthase kinase 3 (GSK3), hypoxia inducible factor 1α (HIF1α), Janus kinase 2 (JAK2), c-jun N-terminal
kinase (JNK), lymphocyte enhancing factor (LEF), tyrosine-protein kinase (LYN), mitogen-activated protein kinase (MAPK), nuclear factor of activated T-cells (NFAT), Nuclear factor kappa
B (NF-κB), phosphatoinositide-3-kinase-γ polypeptide (PI3Kγ), protein kinase C (PKC), phospholipase C (PLC), Ras-related C3 botulinum toxin substrate 1 (RAC1), stress-activated
protein kinase (SAPK), serum response factor (SRF), signal transducer and activator of transcription 3 (STAT3), T-cell factor (TCF).
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2. Different Endocytic Pathways
In general, endocytosis is divided into two processes: pinocytosis, by which cells take in fluid and
small particles, and phagocytosis, which is performed by specialised cells that have the capacity to
uptake larger particles (>500 nm) such as microorganisms and cell debris (Figure 1). Pinocytosis is
further divided into macro- and micropinocytosis. By macropinocytosis, cells take in extracellular fluid
via large endocytic vesicles which are heterogeneously sized (200–500 nm) termed macropinosomes.
In micropinocytosis, specific molecules enter the cell through smaller vesicles and can be further divided
to clathrin-mediated endocytosis (70–150 nm) (CME), caveolae-mediated endocytosis (60–80 nm) or
non-coated vesicles (Figure 1) [3,17].
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Figure 1. Schematic representation of different endocytic pathways in mammalian cells. The 
endocytosis is divided into various subgroups based on the size of the cargo entering the cell. 
Different membrane proteins are involved in clathrin and caveolin-mediated pathways and the fate 
of cargo molecules depends on specific endocytic mechanisms. Lysosomes (LYSO), adaptor protein 2 
(AP2), early endosomes (EE). 
After pinching off the PM, the majority of endocytic vesicles are fused with early endosomes 
where the cargo is sorted. Later, it can either recycle back to the PM or it can be directed into 
degradation pathways. Late endosomes are formed via fusion of early endosomes in an endosome 
maturation process, where the structures of membrane proteins change. After endosome maturation, 
the recycling to the PM stops and non-recycled material is further directed into degradation pathways 
[18]. Degradation takes place in lysosomes, which are formed by fusion of late endosomes and pre-
existing lysosomes. During maturation, transport from the trans-Golgi network to endosomes occurs, 
providing newly synthesized lysosomal enzymes for the endosomes [19]. 
  
Figure 1. Schematic representation of different endocytic pathways in mammalian cells. The endocytosis
is divided into various subgroups based on the size of the cargo entering the cell. Different
membrane proteins are involved in clathrin and caveolin-mediated pathways and the fate of cargo
molecules depends on specific endocytic mechanisms. Lysosomes (LYSO), adaptor protein 2 (AP2),
early endosomes (EE).
After pinching off the PM, the majority of endocytic vesicles are fused with early endosomes where
the cargo is sorted. Later, it can either recycle back to the PM or it can be directed into degradation
pathways. Late endosomes are formed via fusion of early endosomes in an endosome maturation
process, where the structures of membrane proteins change. After endosome maturation, the recycling
to the PM stops and non-recycled material is further directed into degradation pathways [18].
Degradation takes place in lysosomes, which are formed by fusion of late endosomes and pre-existing
lysosomes. During maturation, transport from the trans-Golgi network to endosomes occurs, providing
newly synthesized lysosomal enzymes for the endosomes [19].
2.1. Clathrin-Mediated Pathway
The most extensively studied form of endocytosis is the clathrin-mediated pathway, which occurs
in all mammalian cells. This pathway has traditionally been described as the most commonly used
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endocytic pathway for the majority of GPCRs [20]. Among vGPCRs, US28 and ORF74 use the
clathrin-mediated pathway as one of the mechanisms for internalization, however, their mechanism for
cell entry is promiscuous, as described later. A clathrin-coated vesicle forms on the PM and is coated
with the protein clathrin on its cytosolic face. This plays a central role for receptor internalization
and recycling, but also for the uptake of numerous important molecules such as nutrients, antigens,
growth factors, and pathogens [21]. The CME is divided into the following stages: coat nucleation and
assembly, coated pit maturation, fission, and uncoating [22].
The clathrin coat assembles on the cytosolic surface of the PM and is composed of different
components: adaptor proteins, cargo, lipids, and clathrin [22]. Clathrin, the most important component
of the coat, comprises of three clathrin heavy chains (CHC) and three clathrin light chains (CLC). Its
recognisable structure is also termed triskelion. With clathrin polymerisation, a lattice-like structure
forms around the vesicle. Since clathrin is unable to directly bind to the lipid and protein components
of the PM, it requires adaptor proteins which link the clathrin coat with the PM and specific cargo
assembled on PM [6,23].
Adaptor protein 2 (AP2) is the major adaptor protein which is bound to the membrane
phosphatidylinositol. It consists of four subunits: two larger α and β2 and two smaller µ2 and
σ2. Via the α subunit, AP2 binds to phosphatidylinositol that anchors AP2 at the PM. β2 subunit
binds the heavy chain of clathrin and therefore links clathrin to the PM. The µ2 subunit recognises
specific tyrosine motifs (YXXΦ; Φ represents a hydrophobic residue (V, I, L, F, W, Y, M)) on integral
membrane receptors, which triggers their selective arrangement in clathrin rich areas. AP2 can bind to
receptors via other adaptor proteins such as the β-arrestins which bind to the β2 subunit of AP2 [21,24].
Binding to β-arrestins is not obligatory for receptor internalization as observed in US28 and ORF74.
For US28, constitutive β-arrestin independent clathrin-mediated internalization has been described in
MEF (mouse embryonic fibroblasts) cells, where both β-arrestin 1 and β-arrestin 2 were depleted [25].
For ORF74, the difference in β-arrestin recruitment was observed by comparing ligand-induced and
constitutive internalization. CXCL1 and CXCL8 mediated rapid endocytosis relies on recruitment of
both β-arrestin-1 and -2, whereas constitutive endocytosis does not require β-arrestins, comparable to
US28 [26].
Epsin and eps15 are adaptor proteins with ubiquitin-interacting motifs. Therefore, they direct
ubiquitin tagged cargo into clathrin-coated vesicles. Different proteins such as AP180 and CALM
mediate the size of the clathrin-coated vesicle. AP180 is found in neurons and CALM is ubiquitously
spread [22].
Formation of a clathrin-coated vesicle involves PM bending, which occurs under the influence of
protein endofilin, amphiphysin, and epsin. Amphiphysin binds to clathrin, AP2, and dynamin [6].
Dynamin GTPases are necessary for pinching off mature clathrin-coated vesicles. After clathrin-coated
vesicles enter the cell they rapidly depolymerize their clathrin coat into units under the influence of
cytosolic chaperone Hsc70, which catalyses the depolymerization [21].
Specific motifs located at the C-terminal domains of transmembrane proteins determine recruitment
in clathrin-coated vesicles. There are four types of motifs recognized: YXXΦ (interacts with µ2 subunit
of AP2), [DE]XXXL[LI] (recognized by β2 subunit of AP2 and α/σ2 hemicomplex), FXNPXY (interacts
with µ2 subunit of AP2) and polyubiquitination (recognized by epsin and Eps15) [24,27]. In this article
the internalization motifs recognized in vGPCRs US28, ORF74, and BILF1 are presented (Table 2).
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Table 2. Predicted eukaryotic linear motifs (ELM) in vGPCRs.
Receptor Elm Name
Instances
Positions Elm Description Cell Compartment(Matched Sequence)
EBV-BILF1 TRG_ENDOCYTIC_2 YSAF 32–35 [A] Tyrosine-based sorting signal responsible





PLHV1-BILF1 TRG_ENDOCYTIC_2 YTTL 179–182 [A] Tyrosine-based sorting signal responsible





PLHV2-BILF1 TRG_ENDOCYTIC_2 YAVL 159–162 [A] Tyrosine-based sorting signal responsible





PLHV3-BILF1 TRG_ENDOCYTIC_2 YAAL 194–197 [A] Tyrosine-based sorting signal responsible





US28 TRG_ENDOCYTIC_2 YYAI 130–133 [A]
Tyrosine-based sorting signal responsible










ORF74 TRG_ENDOCYTIC_2 YGLF 326–329 [A] Tyrosine-based sorting signal responsible





Molecules 2020, 25, 5710 9 of 23
Eukaryotic linear motifs (ELMs) are protein interaction sites important for regulation of different
biological roles exploited by proteins. We investigated known endocytosis-related ELMs of six vGPCR
(EBV-BILF1, PLHV1-BILF1, PLHV2-BILF1, PLHV3-BILF1, HCMV-US28, and KSHV-ORF74) using ELM
resource database [28]. The obtained pattern of conserved amino acids, which is a set of sequences that
can be related to molecular function, is common for all and is MVIF. Probability was also calculated
for each ELM class and was same for all (p = 0.0259) and should reflect the probability of the regular
expression to be found by chance in any given protein sequence. All six receptors encode YXXΦ sorting
signal, which interacts with the µ2 subunit of AP2 complex in clathrin-coated vesicles. This observation
is in line with previously described observations for US28 and ORF74, where functional interaction
with the AP2 complex was proven [25,29]. However, BILF1 receptors have not been functionally
characterized yet in respect to their endocytic strategies. Based on these predicted ELMs observed for
BILF1 receptors, it is our aim to test and describe routes these receptors use in endocytic trafficking.
Each of these vGPCRs were also checked for nucleotide base sequence similarities (BLAST,
NCBI). EBV-BILF1, showed sequence similarities to other Herpesvirales (taxid: 548681), but no high
homology outside of this taxid, indeed all returns showed herpesvirus 4. PLHV1-BILF1 again stayed
within the Herpesvirales with 92.5% homology to PLHV2, 75.59% to PLHV3, 99.92% PLHV1 and
100% with porcine gamma-herpesvirus envelope glycoprotein B (gpB) gene, however their query
covers amounted to just 81%, 50%, 3%, and 3% respectively. Hits with myotis gammaherpesvirus 8,
rhinolophus gammaherpesvirus 1, and cricetid gammaherpesvirus 2 were also observed but with low
query covers. PLHV2-BILF1 naturally had homologies with various porcine herpesvirus 2 sequences
but also with PLHV3 (76.05% with 46% query coverage) and PLHV1 and porcine gamma-herpesvirus
envelope glycoprotein B (~93% with just 4% query coverage), with bovine gammaherpesvirus 6,
rhinolophus gammaherpesvirus 1, human gammaherpesvirus 8 and herpesvirus 8 type M all featuring
on the distance tree. PLHV3-BILF1, showed similarities between lymphotropic herpesvirus 1 and 2
(98.3% and 78.32% with query coverage of 11% and 9% respectively). Once coverage was under 3%
only molossus molossus gammaherpesvirus 1 isolate and alcelaphine gammaherpesvirus 1 strains
showed similarities. HCMV-US28 naturally showed similarities with the differing human herpesvirus
5 strains, whilst KSHV-ORF74 sequence similarity matches mainly came up with human herpesvirus
8, human gammaherpesvirus Kaposi’s sarcoma-associated herpesvirus glycoprotein M (all of which
were observed with 97–100% homology to differing sequences).
2.2. Caveolae
Caveolae are flat to flask shaped, 60–80 nm wide membrane pits, rich in the protein caveolin.
They are enriched in certain cell types such as fibroblasts, smooth muscle cells, endothelial cells,
and adipocytes and are involved in endocytosis and transcytosis as well as in calcium signalling and
other signal transduction events. They are also involved in endocytosis of different pathogens [30].
Furthermore, internalization of different membrane components such as extracellular ligands, bacterial
toxins and viruses (SV40, Polyoma viruses) can occur through caveolae [6]. Three types of caveolins
(CAV 1, 2, 3) are important for caveolae formation. They all possess specific hairpin structures in both
N- and C-terminus and in their long U-shaped intermembrane part. Caveolae formation with CAV
1 and 3 is closely related with lipid rafts, since these two proteins are mainly located in cholesterol,
sphingolipids, and sphingomyelin rich parts of membrane. Dynamin is responsible for pinching off
caveolae from the PM [30]. After entering the cell, caveolae can either fuse with early endosomes
(this process depends on Rab5 protein presence), or caveosomes (this process is independent of Rab5
protein) or are recycled back onto the PM [31]. By utilizing caveolae mediated cell entry, different
pathogens (bacteria, viruses) avoid degradation in lysosomes and thereby prolong their survival in
cells [30].
Molecules 2020, 25, 5710 10 of 23
2.3. Lipid Rafts
Lipid rafts are small (10–200 nm), mobile, heterogeneous, and detergent resistant domains
enriched in cholesterol, sphingolipids, glycosylphosphatidylinositol (GPI-anchored protein),
and glycosphingolipid. Lipid rafts play important roles in different aspects of cellular physiology,
although specific mechanisms of their functions are still not clear [32]. It has been described that
various immune receptors are translocated to lipid rafts upon their activation as a consequence of high
signalling molecule concentration in these areas [33–35]. Many viruses bind to lipid rafts to initiate
their further entry into the cell. They either bind to glycolipids enriched in the lipid rafts or to different
viral receptors [36]. Moreover, it is also known that different bacterial toxins (Shiga toxin and Cholera
toxin) and certain viruses (Polyoma virus and simian virus 40) use specific PM lipids as receptors for
endocytosis [37]. It has recently been proposed that novel corona virus SARS-CoV-2 uses lipid rafts for
entering into the host cell by binding ACE2 (angiotensin converting enzyme 2) which is enriched in
lipid rafts, however, further studies are required [38]. It has also been suggested that viral budding of
HIV can occur in lipid rafts due to their enrichment of cholesterol molecules [39].
Various lipid raft-dependent pathways have been described, with caveolae dependent endocytosis
being one of them. GPI-anchored proteins, endothelin, growth factors, and glycolipids exploit
lipid rafts for endocytosis [40]. A potential role of lipid rafts has also been described for US28.
This receptor is enriched in detergent-resistant membrane fractions and is palmitoylated at the
C-terminal end upon receptor activation. This process acts as a targeting signal that directs the
receptor to caveolae. However, co-localization of US28 with caveolin was not detected indicating a raft
dependent, caveolin-independent pathway for US28 [41].
3. Endocytic Properties of The Most Commonly Studied vGPCRs
3.1. Cytomegalovirus (CMV)
Cytomegalovirus is a severe virus which causes deadly infections among immunosuppressed
patients [42]. Human cytomegalovirus (HCMV) open reading frames (ORF) encodes four vGPCRs:
US28, US27, UL33, and UL78; the first three mimic chemokine receptor structure. Mouse and rat CMV
encodes homologs of UL33 and UL78, but not US28 and US27 [12].
US28 is an extensively studied receptor that has been shown to be functionally important in
various aspects of HCMV infection. It displays high constitutive (ligand independent) activity and
binds a broad range of chemokines [43–45]. It is the first vGPCR used as an antiviral drug target to
selectively kill HCMV infected cells using fusion toxin protein [46–48]. This strategy relies on the ability
of this receptor to internalize constitutively and thereby deliver the immunotoxin intracellularly [25,47].
The majority of US28 receptors is located intracellularly in endosomes in the perinuclear region with
only a small amount located in the PM (Figure 2). It was revealed that constitutive endocytosis is
β-arrestin independent; nevertheless, it still employs a pathway through clathrin-coated vesicles as
shown in embryonic fibroblasts acquired from β-arrestin-1 and -2 knockout mice using siRNA against
the µ2 subunit of AP-2 adaptor protein [25]. When comparing the endocytosis of US28 in the control
and β-arrestin knockout cells, no differences were observed [25].
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It is assumed that US28 internalization could partially use caveolae or lipid rafts, since 
palmitoylation of US28 has been observed. Palmitoylation is a step in the receptor activation process 
and serves as a targeting signal for receptors to caveolae [41]. Typically, after ligand-mediated 
receptor activation, the C-terminal tail is phosphorylated, which eventually leads to β-arrestin 
binding and endocytosis. The C-terminal tail of US28 receptor contains many serine and threonine 
residues which represent potential phosphorylation sites. Research shows that the C-terminal end is 
constitutively phosphorylated, therefore it enables the constitutive activity of receptors [25]. 
Similar to US28, US27 and UL33 (HCMV) are located intracellularly. The intracellular 
localization of UL33 was however only observed in HeLa and COS-7 cells, but not in HEK-293, where 
the receptor was mostly located at the PM. This suggests that the receptor localization is cell type 
specific. Co-localization of US27-YFP/UL33-GFP with LAMP1, the marker of late 
endosomes/lysosomes, was shown in Hela cells, which indicates that these receptors are located in 
late endocytic compartments [49]. It is believed that localization within these compartments enables 
US28, US27, and UL33 to bud into a viral membrane when the virus is exiting the cell [49]. 
Immunohistochemistry on cryosections showed that UL33 is located at multivesicular bodies (MVB), 
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through lysosomes [49]. 
When co-expressing US27 and US28, colocalization was observed, suggesting that both proteins 
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similarly internalized and revealed that a large amount of this receptor is found in intracellular 
vesicles, indicating receptor internalization in a constitutive manner, like for US28 [49]. 
Figure 2. Endocytic mechanisms employed by vGPCRs. Different vGPCRs use different mechanisms
to enter the cell. Besides ligand dependent endocytosis (as shown on the Figure for US28 with ligands
CCL5 and CCL2 and for ORF74 with ligands CXCL10, CXCL 12 and VCCL2), constitutive (ligand
independent) endocytosis is a common feature observed for these receptors. The fate of receptors inside
the cell is tightly regulated and has an important impact on receptor function outcome. Localization of
vGPCRs differs, with ORF74 and BILF1 receptors predominantly localizing at the surface and US28
localizing intracellularly in 80% and at the surface at 20%. Endosomes (endo), recycling (Rec), β-arrestin
(β-arr), early endosomes (EE), lysosomes (LYSO).
It is assumed that US28 internalization could partially use caveolae or lipid rafts,
since palmitoylation of US28 has been observed. Palmitoylation is a step in the receptor activation
process and serves as a targeting signal for receptors to caveolae [41]. Typically, after ligand-mediated
receptor activation, the C-terminal tail is phosphorylated, which eventually leads to β-arrestin
binding and endocytosis. The C-terminal tail of US28 receptor contains many serine and threonine
residues which represent potential phosphorylation sites. Research shows that the C-terminal end is
constitutively phosphorylated, therefore it enables the constitutive activity of receptors [25].
Similar to US28, US27 and UL33 (HCMV) are located intracellularly. The intracellular localization of
UL33 was however only observed in HeLa and COS-7 cells, but not in HEK-293, where the receptor was
mostly located at the PM. This suggests that the receptor localization is cell type specific. Co-localization
of US27-YFP/UL33-GFP with LAMP1, the marker of late endosomes/lysosomes, was shown in Hela
cells, which indicates that these receptors are located in late endocytic compartments [49]. It is
believed that localization within these compartments enables US28, US27, and UL33 to bud into a viral
membrane when the virus is exiting the cell [49]. Immunohistochemistry on cryosections showed that
UL33 is located at multivesicular bodies (MVB), but it is still unknown whether UL33 can recycle back
to the PM or it enters a degradation pathway through lysosomes [49].
When co-expressing US27 and US28, colocalization was observed, suggesting that both proteins
are located in late endosomes/lysosomes. Based on this overlap, it was examined whether US27 is
similarly internalized and revealed that a large amount of this receptor is found in intracellular vesicles,
indicating receptor internalization in a constitutive manner, like for US28 [49].
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Little is known about UL78. It is believed, that this receptor is not necessary for viral replication in
cell cultures, but its function in vivo remains to be studied [49]. This receptor is mainly localized within
the cytoplasm of the endoplasmatic reticulum, although surface expression has also been proposed.
Furthermore, it has been shown that UL78 undergoes constitutive endocytosis and recycling back to
PM [50].
3.2. Kaposi’s Sarcoma Associated Herpesvirus (KSHV)
The ORF74 receptor family is encoded by γ2-herpesviruses, such as: KSHV, MHV68, HVS,
AtHV, and EHV2. They bind CXC chemokines, and most often also display constitutive activity.
ORF74 encoded by KSHV is the most thoroughly characterized receptor in this group, followed by
ECRF3 from HVS. Both bind CXC-chemokines; KSHV-ORF74- with a broader spectrum compared
to ECRF3-HVS [51–55]. The constitutive signalling of KSHV-ORF74-has been directly linked to
tumorigenesis in several mouse models [56–58]. In terms of cellular localization, KSHV-ORF74- has
been described to be mostly located at the PM (Figure 2), but also to undergo internalization.
CXCL1-, and CXCL8-mediated endocytosis was shown to depend on β-arrestin 1 and 2, whereas
the constitutive endocytosis occurs independently of β-arrestin [26]. The AP-2 complex plays an
important role in constitutive internalization of ORF74 (Figure 2). This adaptor complex is also
important for clathrin-coated vesicles mediated endocytosis [29]. After internalization, the receptor is
found in early endosomes, and from there it recycles back at the PM or it fuses with lysosomes and
enters the degradation pathway [59].
3.3. Epstein-Barr Virus (EBV) and Its Closely Related Lymphocryptoviruses
The first BILF1 receptors were recognized as GPCR’s in 2005 [60]. They are encoded by different
γ-1-herpesviruses (EBV, other primate lymphocryptoviruses, porcine lymphotropic herpesviruses
(PLHV1, 2, 3) and other ungulate gammaherpesviruses) [61–63]. The sequence identity of BILF1
receptors varies, with ape γ-1 herpesvirus BILFs being highly conserved and ungulate γ-1 herpesvirus
BILFs being more distantly related [63]. However, ORF encoding BILF1 receptors was described for all
above mentioned γ-1 herpesviruses at a similar genomic position [64–66]. Functionally, EBV-BILF1
remains the most studied among BILF1 receptors until this day. It is an orphan receptor with
well-established constitutive signalling and internalization properties. Confocal microscopy has shown
that EBV-BILF1, similar to KSHV-ORF74-, predominantly locates at the cell surface, but there is a
difference among BILF1 orthologs of this family [60,63]. Studies of BILF1 receptors from different
primate lymphocryptoviruses showed that BILF1 receptor encoded in PtroLCV1 (lymphocryptovirus
from chimpanzee) and PpygLCV1 (Lymphocryptovirus from orangutan) predominantly locates
intracellularly and not at the PM. It was therefore shown that localization is not preserved among
the family [63]. However, EBV-BILF1 has been shown to internalize in a constitutive manner [63],
a cellular phenomenon that seems linked to the main function of BILF1 as a MHC-1 downregulating
molecule [15]. This immunevasive property has also been confirmed for RhLCV-BILF1, but not for
CalHV3-BILF1 [15,67]. Further investigation on BILF1 mediated endocytic routes is therefore needed
in order to fully understand its functional properties.
4. Methodological Approaches and Novel Techniques to Study Receptor Mediated Endocytosis
GPCR internalization studies are carried out using different methods. The majority of these use
the receptor linked with specific epitopes (HA, FLAG-tag, SNAP-tag, CLIP-tag), which enables binding
of specific antibodies and therefore receptor detection in cell [68].
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4.1. Real-Time Internalization Assay
To study the dynamics of internalization and recycling in real-time, a novel method based on
time-resolved fluorescence resonance energy transfer (TR-FRET) is used (Figure 3). This method
uses an N-terminal receptor tag (called SNAP-tag), a 20 kDa mutant of the DNA repair protein
O6-alkylguanine-DNA alkyl transferase. It has no restrictions regarding cellular localization and
expression in different cell lines. SNAP-tag is labelled with a tag-lite® SNAP Lumi4®-Tb substrate
(donor), a cell impermeable substrate chemically inert towards other proteins. After one-hour labelling,
the donor is washed off and fluorescein (acceptor) is added to the cells. During the measurement,
excitation of the donor causes the energy transfer to acceptor resulting in quenching of the donor
emission [69].
Molecules 2020, 25, x  14 of 24 
Molecules 2020, 25, x; doi: 
expression in different cell lines. SNAP-tag is labelled with a tag-lite® SNAP Lumi4®-Tb substrate 
(donor), a cell impermeable substrate chemically inert towards other proteins. After one-hour 
labelling, the donor is washed off and fluorescein (acceptor) is added to the cells. During the 
measurement, excitation of the donor causes the energy transfer to acceptor resulting in quenching 
of the donor emission [69]. 
 1 
Figure 3. Methods to study GPCR internalization. Different approaches can be used for receptor 
internalization analysis. 
With this method, agonist-induced and constitutive internalization can be followed in real-time 
(Figures 3 and 4). To obtain the best detection of constitutive internalization, labelling of surface 
receptors with tag-lite® SNAP Lumi4®-Tb must be performed at 4 °C to prevent endocytosis during 
the labelling process. Further, to allow for receptor internalization; measurements are performed at 
37 °C. When observing agonist-induced internalization, labelling is usually performed at 37 °C, since 
the internalization is later triggered by addition of the agonist [69]. This novel sensitive method offers 
cost effective, fast, high throughput approaches to study ligand-induced or constitutive receptor 
internalization kinetics. Its limitation is the use of relatively large SNAP-tag on receptors, which could 
potentially change receptor localization and signalling patterns. Therefore, an additional comparison 
of SNAP-tagged and WT receptor, as for example receptor signalling, is needed prior the assay. 
i re 3. et s t st i ter alizati . Different a roaches ca e se f r rece t r
internalization analysis.
With this method, agonist-induced and constitutive internalization can be followed in real-time
(Figures 3 and 4). To obtain the best detection of constitutive internalization, labelling of surface
receptors with tag-lite® SNAP Lumi4®-Tb must be performed at 4 ◦C to prevent endocytosis during
the labelling process. Further, to allow for receptor internalization; measurements are performed
at 37 ◦C. When observing agonist-induced internalization, labelling is usually performed at 37 ◦C,
since the internalization is later triggered by addition of the agonist [69]. This novel sensitive method
offers cost effective, fast, high throughput approaches to study ligand-induced or constitutive receptor
internalization kinetics. Its limitation is the use of relatively large SNAP-tag on receptors, which could
potentially change receptor localization and signalling patterns. Therefore, an additional comparison
of SNAP-tagged and WT receptor, as for example receptor signalling, is needed prior the assay.
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As an example of this technique applied for the vGPCRs, we SNAP-tagged EBV-BILF1 and the three
porcine herpesvirus-encoded (PLHV1-3) BILF1 receptors and determined constitutive internalization
of all four receptors (Figure 4). F r receptors, labelled with the donor molecul at 37 ◦C, only a small
increase in internalization was observed. This is mainly because th labelled receptors had alre dy
reached an equilibrium of the internalization/recycling process during the labelling period. Therefore,
we performed the labelling of receptor at 4 ◦C to prevent a y constitutive internalizati n in this period.
With this appr ach, the internalizati n was increased.
4.2. Antibody Feeding Assay
Antibody feeding allows determination of receptor endocytosis at different time points on fixated
cells. In principle, studied receptors must be specifically labell d with antibodies that recognize specific
epitopes on the N-terminal site of the receptors. Use of recombinant receptors tagged with eng neered
extracellular tags (for example FLAG, HA, Myc) are very common and specific antibodies gainst these
tags are comm rcially available.
Antibody feedin can be performed using two different principles. With ELISA assays, one of the
most useful methods for determinati n of receptor surface xpression, th amount of surf ce expressed
rec ptors can be quantitatively assessed over tim . Sec ndly, using a micr scopy pproach, surface
expres ion, and in e nalized r ceptors, they can be vi ualized in diff rent time points after induction of
internalization. Internalization can be induced by ligands targeting th studied receptors or in case
of con titutively a ve recep o s by inducing a temperature shift. Thereby, it is possible to prevent
internalization by c oli g the cells (i cuba ion at 4 ◦C) and induce internalization by incubating the
cells at temperatures of 18 ◦C or high (usu lly 37 ◦C).
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In both principles, initial incubation with specific primary antibodies at 4 ◦C prevents
internalization processes and allows labelling of only surface expressed receptors. Afterwards, cells are
incubated at 37 ◦C (with or without the ligand) for various time points, allowing the receptors to
internalize. Following internalization, cells are fixed and in case of ELISA stained with horseradish
peroxidase-conjugated secondary antibodies. In the presence of horseradish peroxidase substrate,
secondary antibody gives a reaction of the supernatant and its optical density (OD) can be measured
with ELISA plate readers. By this we can determine the amount of the receptors expressed at the cell
surface in different time points quantitatively.
Performing microscopy experiments, incubation at 37 ◦C and additional fixation is followed by
labelling with the first secondary antibody labelled with a specific fluorophore (for example Alexa 488)
that visualizes labelled receptors at the cell surface. Cells are then additionally permeabilized and
incubated with another secondary antibody (for example Alexa 647 antibodies) that labels internalized
receptors and unlabelled receptors at the cell surface. This way, we can differentiate between the
amount of surface remaining receptors and internalized receptors [68–70]. Antibody feeding assays
provide direct visualisation of receptor internalization at specific time points. Despite these benefits,
the procedures require a few washing steps and temperature shifts, which can affect cell morphology
and viability.
Antibody feeding has been used to determine constitutive internalization of EBV-BILF1,
PtroLCV1-BILF1, PpygLCV1-BILF1, and SsynLCV1-BILF1 where all described receptors localized into
intracellular compartments after 30 min [63]. Further, for US28, both internalization and recycling
were confirmed by antibody feeding assay using microscopy approach. In the case of recycling,
after incubation with the first antibody, cells were washed and additionally re-incubated with another
antibody for 1h at 37 ◦C. Receptors that recycled to the cell surface were stained with the secondary
antibody and internalized again [71].
4.3. Fluorescence-Activate Cell Sorting (FACS)
FACS can quantitatively determine the decrease of receptors expressed at the cell surface after
ligand addition or in case of constitutive internalization by a temperature shift. Receptors can
be detected in several different ways. Similar to ELISA, receptors can be labelled by N-terminal
epitope-tags and subsequently incubated with specific primary antibodies directly conjugated with
a fluorescent dye. Receptors can also be tagged with a fluorescent tag (for example GFP). Changes
in surface expression of the receptor can be measured in different time points. With this method,
receptor internalization and recycling rates can be estimated accurately, as it allows the measurement
of properties on a single cell in solution [72,73].
4.4. Microscopy Based Approaches
Currently, fluorescence microscopy is important and represents a constantly evolving tool in the
field of bioscience. When studying receptor trafficking, an initial determination of receptor cellular
localization is needed. To determine GPCR localization, fluorescence microscopy is usually used.
Receptors can be either stained with a fluorescent antibody against a specific tag or tagged with
intrinsically fluorescent protein (green fluorescent protein (GFP)). With confocal microscopy, we can
collect serial optical sections from thick specimens at around 300 nm resolution, which enables us to
determine receptor localization in the cell with good precision. To observe internalization, antibody
feeding approaches can be used (as discussed above).
One of the leading approaches in the field of single-molecule fluorescence microscopy is TIRF
(Total Internal Reflection Fluorescence). TIRF is especially useful for visualization of molecules at the
cell surface, making it ideal for studying GPCRs. It requires the use of fluorophore tags (eGFP, SEP or
SNAP) that might disrupt general properties of wild type receptors, therefore functional analysis of
tagged receptors is crucial [74–76].
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For confocal microscopy, more than only one type of antibody can be used in a single assay,
enabling us to determine co-localization of different receptors and/or proteins [72]. As a marker for
recycling endosomes, antibodies against the transferrin receptor are used; for endosomes/lysosomes,
antibodies against LAMP1 or CD63 are used as exemplified by studies on US28, US27, and UL33.
US28 co-localized with markers for recycling endosomes and late endosomes/lysosomes, whereas
US27 and UL33 significantly co-localized with markers for late endosomes/lysosomes but not with
markers for recycling endosomes [49,71]. The Golgi network is marked with antibodies against γ
subunit or adaptor complex 1 [49]. For colocalization with the endoplasmic reticulum (ER), the marker
calnexin is commonly used. Rab proteins are specific markers of the endocytic route. Different proteins
mark different intracellular organelles which play roles in endocytosis. Rab5 is a marker for early
endosomes and is a very important protein in the first step of endocytosis. Rab4 and Rab11 are linked
to the recycling process, whereas Rab4 also mediates fast and direct recycling to the PM whilst Rab11
mediates slow recycling from recycling endosomes, usually located in the perinuclear region. Rab7 is a
marker for late endosomes/lysosomes. It marks the degradation pathway [77].
4.5. Manipulation of Endocytic Pathways
4.5.1. Chemical Inhibitors
To better understand different types of endocytosis, researchers have developed different methods
to block these processes. By using these pathway inhibitors, it is possible to assess which cell structures
are responsible for certain type of endocytosis. Different pharmacological agents can represent
good tools for cell manipulation with their direct inhibition of specific processes. Disadvantages are
non-specificity and their ability to interfere with other cell processes [78]. CME is blocked by decreased
cytosolic pH, which restrain clathrin vesicles on the PM and disables their removal from the PM [68].
Monodansylcadaverine (MDC) is a tissue transglutaminase inhibitor that participates in clathrin
assembly and internalization [68]. Hypertonic sucrose is the most widely used agent, which prevents
CME, causing cell shrinkage. It is believed that sucrose also affects endocytosis by caveolae, therefore
it is a non-specific endocytic blocker. With potassium depletion, clathrin aggregation occurs in the
cytoplasm, which prevents its accumulation on PMs. Chlorpromazine mediates the accumulation
of adaptor proteins and clathrin on endosomal membranes, thus preventing the assembly of these
proteins on PMs [79]. It also prevents the receptor recycling back to the PM in different endocytic
pathways [78]. Pitstop2 is a novel transferrin inhibitor, which interrupts binding between terminal
domain of clathrin and amphiphysin [68]. Temperature is another factor influencing endocytosis.
CME is blocked under 16 ◦C for example [78].
Regarding the fact that caveolae mediated endocytosis occurs on lipid rafts, cholesterol depletion
in the PM blocks caveolae formation [68]. Cyclodextrins are used for this purpose, but besides their
influence on endocytic routes, they also change the membrane structure, therefore influencing different
endocytic pathways. As an alternative, filipin can be used. By binding to cell surface cholesterol, it
prevents the biding of other molecules, but is cytotoxic in higher quantities [78]. Dynamin is important
in both clathrin-mediated and caveolae-mediated endocytosis. At the membrane, it pinches-off newly
formed vesicles and allows them to release from the surface. Dynasore has been recently described as a
chemical inhibitor of dynamin and can be used for manipulation of both clathrin and caveolin-mediated
endocytosis [80].
4.5.2. Genetic Manipulation
To avoid nonspecific effects of chemical inhibitors, different genetic approaches have been
developed for endocytic inhibition. These approaches alter the expression of proteins, important for
normal receptor endocytosis and includes knockout models, overexpression of dominant negative
mutants and protein silencing with siRNA.
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The best way to determine a role of a specific protein is gene inactivation. There are plenty of
different knockout mouse models available, lacking expression of different proteins [81]. For the
purpose of endocytic studies, mouse embryonic fibroblasts (MEF) from β-arrestin knockout mice (βarr
1/2-KO cells) are widely used, to determine whether endocytosis is β-arrestin dependent as exemplified
for US28 [82].
CRISPR-cas9 (clustered regulatory interspaced palindromic repeats) is a novel method used for
gene knockout. This mechanism is a defence mechanism against viruses and other invaders used by
prokaryotes. Its simplicity was exploited for use in mammalian cells for the purpose of genome editing.
Two components are involved in this mechanism: Cas9 protein, an enzyme which cuts DNA and
sgRNA, which determines the site of cutting. SgRNA needs to be complementary to the cutting site [83].
CRISPR/Cas9 system was used to prepare dynamin-1 and β-arrestin knockout cells. They used these
cells to evaluate if the absence of these proteins influences endocytosis. Dynamin-1 is an important
component, participating in vesicle scission. In its absence clathrin- and caveolin-mediated endocytosis
is disabled. For this purpose, 20 bp dynamin sgRNA was created and cloned into vector along with
Cas9n. Transfection was used to introduce the vector to the cell. Dynamin-1 expression was later
checked with western blot [84].
Downregulation of protein expression and therefore inhibition of specific types of endocytosis can
be performed using dominant negative mutants and siRNA constructs. Dominant negative mutants of
dynamin (Dyn1 K44A) [85], β-arrestin (β-arrestin 319–418) [86], caveolin (Cav1 S80E) [87], eps15 (Eps15
∆95/295) [88], and epsin (Epsin 1∆UIM) [89] are widely used in different studies determining the
endocytic pathway. Cav1 S80E, β-arrestin 319–418 and Dyn K44A dominant mutants have previously
been used to determine endocytic properties of other GPCRs (e.g., NK1R) [90]. Overexpression of these
mutants in cells masks the wild type protein function, but its function is never completely silenced.
Also, it was proposed that overexpression of dominant negative mutants may cause other indirect
effects in the cell, leading to misinterpreted results [78].
For silencing protein expression, siRNA constructs against different endocytic players are used.
To inhibit the clathrin-mediated pathway, siRNA construct against µ2 subunit of AP2 protein was used
in US28 stably transfected Hela cells [25]. Silencing the expression of this protein clearly indicated the
requirement for µ2-adaptin subunit and therefore CME in US28. However, the time taken to inhibit the
expression of these proteins is long (3–7 days). During this time cells can adjust to protein deficiency
or can also change the expression of other genes [78].
Morpholino oligomers/morpholino antisense oligonucleotides (MO) have also been used to
understand knockdown effects of GPCRs. They are generally the most widely used anti-sense
knockdown tool in zebrafish and are also commonly used in other models such as chick embryos and
frogs [91]. Inhibition of gene expression is undertaken via blocking translation or splice blocking,
preventing assembly of the spliceosome. Although this technology is relatively inexpensive, differing
knockdown yields and off-target effects are always a consideration. The use of standard control
MO, knockdown rescue experiments and use of several different knockdown MOs can help decipher
potential off-target reactions and even increase knockdown levels as differing MOs are used; however,
these are time consuming [92]. GPCRs and regulators ranging from gpr161 through to β-arrestin have
been knocked down using this technology [93,94].
Naturally, there are also increasing amounts of data pertaining to genetic mutation/variation from
published experiments in cell lines through to patients. Whilst the original intention of this work may
not directly look at GPCRs, a range of bioinformatics tools means that the data can be analysed in
relation to several lines of enquiry. Data from gene expression studies, biological responses, clinical
findings, and outcomes data can all be combined, and networks and biomarkers may well be observed
from these studies in relation to GPCRs or factors associated with them. Therefore, data mining and
the large range of genomics/bioinformatics tools now available provide an invaluable resource.
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5. Conclusions
GPCRs play important roles in virus life cycle from the primary infection, replication, and latency
establishment to various pathological outcomes. In this respect, understanding molecular and cellular
behavior is of huge importance. This review has focused on three thoroughly studied vGPCRs
(HCMV-US28, KSHV-ORF74, and EBV-BILF1 and homologs of these) in terms of endocytic properties
as well as novel methods used for characterization of endocytic properties. Despite their distant
genetic relationships, US28, ORF74, and BILF1 receptors have been linked to the development of cancer.
ORF74 was described as the driver of KSHV-related malignancies inducing angiogenesis, cellular
transformation, and inflammation [56,58,95]. HCMV-US28 has been detected in glioblastoma and
colorectal cancers and is described as an onco-modulator constitutively upregulating angiogenesis and
proliferation [96,97]. For BILF1, constitutive Gαi dependent signaling has been linked to EBV-mediated
cell transformation ability both in vitro and in vivo [98]. The involvement of all three receptor classes
in tumor development makes them attractive drug targets for the treatment of virus-related cancers.
As shown for US28, one potential strategy to target infected cells is the use of fusion toxin protein (FTP)
to specifically target and kill HCMV infected cells [46–48]. For US28, a predominantly intracellular
localization pattern was described as a consequence of a rapid constitutive endocytosis [49,99].
This ability was used for the delivery of the toxin intracellularly. For US28, β-arrestin independent,
constitutive CME has been shown. This is additionally supported by observations that US28 expresses
a YXXΦ motif known to interact with AP-2, a protein important for clathrin coat assembly. A similar
motif was observed in BILF1 receptors from EBV and PLHV1-3, as well as KSHV-ORF74. BILF1 has
recently been described as an immunevasive protein playing a role in downregulating surface expressed
MHC class I molecules [15]. With its cell surface localization, BILF1 has been proposed to bind MHC
class I molecules and internalize in complex leading to its degradation in lysosomes. BILF1 receptors
are a subject of current research interest and further studies into their endocytic properties are currently
ongoing and essential in order to further our knowledge.
Given the close link between signaling and internalization, and for both of these phenomenon a
close link to the pathophysiology of the viruses, future studies of the internalization properties of these
receptors are needed to finally establish how, when, and where to target them from a therapeutic point
of view.
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